SCHEMBL27889239

SCHEMBL27889239

CC(CF)C(C(=O)O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.59
KMT2A Q03164 1/20 0.46
SRC P12931 1/20 0.43
APAF1 O14727 1/20 0.43
LMNA P02545 3/20 0.42
MAPK1 P28482 1/20 0.42
PTGS2 P35354 2/20 0.41
PTGS1 P23219 1/20 0.41
CHRM2 P08172 2/20 0.40
CHRM4 P08173 2/20 0.40
CHRM1 P11229 2/20 0.40
CHRM3 P20309 2/20 0.40
CHRM5 P08912 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL499471 0.82 CYP2D6 (0.61) CYP2D6KMT2ASRCAPAF1LMNA
SCHEMBL23872457 0.82 CYP2D6 (0.61) CYP2D6KMT2ASRCAPAF1LMNA
SCHEMBL28171482 0.82 CYP2D6 (0.61) CYP2D6KMT2ASRCAPAF1LMNA
SCHEMBL4921518 0.82 CYP2D6 (0.61) CYP2D6KMT2ASRCAPAF1LMNA
SCHEMBL27872947 0.80 PTGS2 (0.40) CYP2D6LMNAMAPK1PTGS2PTGS1
SCHEMBL6237736 0.79 CYP2D6 (0.57) CYP2D6KMT2ASRCAPAF1LMNA
SCHEMBL31186930 0.79 CYP2D6 (0.57) CYP2D6PTGS1
SCHEMBL22758148 0.79 PTGS1 (0.44) CYP2D6LMNAPTGS2PTGS1
SCHEMBL9254448 0.78 CYP2D6 (0.55) CYP2D6KMT2ASRCAPAF1LMNA
SCHEMBL27987504 0.78 CYP2D6 (0.67) CYP2D6KMT2ASRCAPAF1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102712577-B Substituted 3-phenylpropionic acids and the use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-10-15 CN disclosed
CN-102712577-A Substituted 3-phenylpropionic acids and the use thereof BAYER SCHERING PHARMA AG 2012-10-03 CN disclosed